Barry M. Lester et al., The Maternal Lifestyle Study: Effects of Substance Exposure During Pregnancy on Neurodevelopmental Outcome in 1-Month-Old Infants, 110 Pediatrics 1182 (2002).
Quote
“We found reliable small differences attributable to drugs that are not necessarily deficits” (p. 1190).
“Cocaine effects are subtle and can be detected when studied in the context of polydrug use and level of cocaine exposure” (p. 1182).
“Long-term follow-up is necessary to determine whether these differences develop into clinically significant deficits” (p. 1182).
“It is now well-documented that early scientific reports in the 1980s that portrayed children who were exposed to cocaine in utero as irreparably damaged were inaccurate” (p.1182).
Article primary conclusion
Lester et al. reported the first neurobehavioral findings from the Maternal Lifestyle Study (MLS), a large prospective, multisite study of prenatal cocaine and opiate exposure. The longitudinal cohort included 1,388 exposed and comparison infants matched on race, sex, and gestational age; 1,211 infants completed neurobehavioral testing at 1 month corrected age. Exposure was assessed using maternal self-report and meconium toxicology, and trained examiners masked to exposure status used the NICU Network Neurobehavioral Scale (NNNS) and acoustic cry analysis.
After adjustment for alcohol, cannabis, tobacco, birth weight, socioeconomic status, and study site, cocaine exposure was associated with small differences in several NNNS measures. Infants with some cocaine exposure had lower arousal scores than unexposed infants, while infants with heavy cocaine exposure showed poorer regulation, greater excitability, and more nonoptimal reflexes than infants with some or no exposure. The authors found no stress/abstinence effects attributable to cocaine exposure, while opiate exposure was associated with more stress/abstinence signs. Most cocaine-related cry differences did not remain after adjustment for covariates, although some opiate-related cry differences persisted.
The authors concluded that neurobehavioral effects associated with prenatal cocaine exposure were subtle, varied by level of exposure, and needed to be interpreted in the context of polydrug exposure and other factors affecting infant development. They emphasized that longer-term follow-up was needed to determine whether these early differences developed into clinically meaningful deficits.
Article context
This was a methodologically strong study for its time: exposure was assessed using both maternal report and meconium testing, examiners were masked to exposure status, and analyses accounted for other prenatal substances, birth weight, socioeconomic status, and study site. However, the neurobehavioral differences were small, their Clinical SignificanceWhat it is: Whether a finding has meaningful real-world impact.Does not mean legally: Statistical significance does not imply legal relevance or material harm.Glossary › was unknown, and the pattern was not a simple dose-response—for example, lower arousal was seen in the “some exposure” group, while heavier exposure was associated with a different pattern of poorer regulation and greater excitability. The cohort was recruited from four urban university-based centers and consisted largely of Black families receiving public assistance, so findings should be interpreted within the social and structural conditions of the population studied rather than generalized automatically to all cocaine-exposed infants. The study supports the presence of subtle group-level differences at 1 month; it does not establish a lasting developmental disorder, clinically meaningful impairment, or the prognosis of an individual infant.
Editor's note
This article marks an important transition in the prenatal cocaine literature. Following reviews such as Frank et al., which challenged claims of severe and distinctive developmental harm, the Maternal Lifestyle Study shifted attention toward detecting more subtle neurobehavioral differences using larger samples and more sensitive measures. Importantly, the authors themselves acknowledge that early portrayals of cocaine-exposed children as “irreparably damaged” were inaccurate and that the differences identified at 1 month were subtle and of uncertain Clinical SignificanceWhat it is: Whether a finding has meaningful real-world impact.Does not mean legally: Statistical significance does not imply legal relevance or material harm.Glossary ›. The MLS population was drawn largely from families experiencing poverty and other social disadvantage, and the study was explicitly designed to consider polydrug exposure and caregiving environment rather than treating cocaine exposure in isolation; these contextual factors should not be understood simply as statistical noise to be “adjusted away,” but as part of the conditions shaping infant and child development.